Complications of HIV disease and antiretroviral therapy.
As antiretroviral treatment regimens become more potent and easier to administer, differences in the rates of adverse events and complications associated with treatment will increasingly drive decisions regarding the selection of therapy. This year's Conference on Retroviruses and Opportunistic Infections featured a wide range of research directed toward understanding the pathogenesis, treatment, and long-term consequences of complications associated with HIV infection and the use of antiretroviral therapy in both resource-limited settings and in the developed world. This review will summarize information on complications of antiretroviral therapy in resource-limited settings, hepatitis C virus, tuberculosis, and discussion of metabolic, cardiovascular, and renal complications.
Havlir
Diane V
DV
University of California San Francisco, CA, USA.
Currier
Judith S
JS
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control; D015658:HIV Infections / Q000150:complications*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced / Q000517:prevention & control; D006525:Hepatitis, Viral, Human / Q000209:etiology / Q000517:prevention & control; D006801:Humans
D044966:Anti-Retroviral Agents